See All Slides -

Slides

Presentation TCT 2012

TAVR Will Be for All!

Presenter: Nicolo Piazza

October 23, 2012

Presentation TCT 2012

DC Devices: Interatrial Shunt for HFPEF

Presenter: Ted Feldman

October 23, 2012

Presentation TCT 2012

Case Presentation: A Complicated ACP Case

Presenter: Jai-Wun Park

October 23, 2012

Presentation TCT 2012

The Spectrum of Early Complications of LAA Closure: Have They Been Eliminated?

Presenter: David Holmes Jr

October 23, 2012

Presentation TCT 2012

TCT-16. Renal Artery Nerve Distribution and Density in the Porcine Model: Biological Implications for the Development of Radiofrequency Ablation Therapies

Presenter: Armando Tellez

October 23, 2012

Presentation TCT 2012

MR with Normal Left Ventricular Ejection Fraction: What Is It and How Should It Be Treated?

Presenter: Patrick O'Gara

October 23, 2012

Presentation TCT 2012

TCT-45. Long Term Safety and Effectiveness of XIENCE V® Everolimus Eluting Coronary Stent System in Real-world Population: Three-Year Clinical Outcomes from the XIENCE V® USA Study

Presenter: James Hermiller Jr

October 23, 2012

Presentation TCT 2012

How Do You Value and Evaluate a Cardiology Practice?

Presenter: Anthony Long

October 23, 2012

Presentation TCT 2012

ELM Presentation

Presenter: J. Dawn Abbott

October 23, 2012

Presentation TCT 2012

DESSOLVE II: A Prospective, Randomized Trial of a Biodegradable Polymer-based Sirolimus-Eluting Stent vs a Zotarolimus-Eluting Stent (Micell)

Presenter: David Kandzari

October 23, 2012

Advertisement

Slides

TAVR Will Be for All!

DC Devices: Interatrial Shunt for HFPEF

Case Presentation: A Complicated ACP Case

The Spectrum of Early Complications of LAA Closure: Have They Been Eliminated?

TCT-16. Renal Artery Nerve Distribution and Density in the Porcine Model: Biological Implications for the Development of Radiofrequency Ablation Therapies

MR with Normal Left Ventricular Ejection Fraction: What Is It and How Should It Be Treated?

TCT-45. Long Term Safety and Effectiveness of XIENCE V® Everolimus Eluting Coronary Stent System in Real-world Population: Three-Year Clinical Outcomes from the XIENCE V® USA Study

How Do You Value and Evaluate a Cardiology Practice?

ELM Presentation

DESSOLVE II: A Prospective, Randomized Trial of a Biodegradable Polymer-based Sirolimus-Eluting Stent vs a Zotarolimus-Eluting Stent (Micell)

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content